ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,287.60
      0.00%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      80.655
      0.05%
      Bitcoin
      93,091.97
      -1.48%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC

      6. Basilea Pharmaceutica Ag Basel NamenAkt (CE) (BPMUF) Quote

      Basilea Pharmaceutica Ag Basel NamenAkt (CE)

      Basilea Pharmaceutica Ag Basel NamenAkt (CE) (BPMUF)

      USOTC
      52.83
      0.00
      (0.00%)
      Closed January 13 4:00PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      52.83
      Bid
      0.00
      Ask
      0.00
      Volume
      -
      0.00 Day's Range 0.00
      38.60 52 Week Range 52.83
      Market Cap
      692.147M
      Previous Close
      52.83
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      13,101,407
      Dividend Yield
      -
      PE Ratio
      57.92
      Earnings Per Share (EPS)
      0.8
      Revenue
      150.28M
      Net Profit
      10.45M

      About Basilea Pharmaceutica Ag Basel NamenAkt (CE)

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.basilea.com
      Headquarters
      Basel, Che
      Founded
      -
      Basilea Pharmaceutica Ag Basel NamenAkt (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker BPMUF. The last closing price for Basilea Pharmaceutica Ag... (CE) was $52.83. Over the last year, Basilea Pharmaceutica Ag... (CE) shares have traded in a share price range of $ 38.60 to $ 52.83.

      Basilea Pharmaceutica Ag... (CE) currently has 13,101,407 shares outstanding. The market capitalization of Basilea Pharmaceutica Ag... (CE) is $692.15 million. Basilea Pharmaceutica Ag... (CE) has a price to earnings ratio (PE ratio) of 57.92.

      Ask ADVFN Intelligence (AI)

      BPMUF Latest News

      More News
      No news to show yet.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      265.8312.40425531914752.83472952.38306122CS
      5214.2336.865284974138.652.8338.63848.51654267CS
      15611.8328.85365853664152.8338.62848.93843609CS
      260-1.66-3.0464305377154.496136.955454.21899974CS

      BPMUF - Frequently Asked Questions (FAQ)

      What is the current Basilea Pharmaceutica Ag... (CE) share price?
      The current share price of Basilea Pharmaceutica Ag... (CE) is $ 52.83
      How many Basilea Pharmaceutica Ag... (CE) shares are in issue?
      Basilea Pharmaceutica Ag... (CE) has 13,101,407 shares in issue
      What is the market cap of Basilea Pharmaceutica Ag... (CE)?
      The market capitalisation of Basilea Pharmaceutica Ag... (CE) is USD 692.15M
      What is the 1 year trading range for Basilea Pharmaceutica Ag... (CE) share price?
      Basilea Pharmaceutica Ag... (CE) has traded in the range of $ 38.60 to $ 52.83 during the past year
      What is the PE ratio of Basilea Pharmaceutica Ag... (CE)?
      The price to earnings ratio of Basilea Pharmaceutica Ag... (CE) is 57.92
      What is the cash to sales ratio of Basilea Pharmaceutica Ag... (CE)?
      The cash to sales ratio of Basilea Pharmaceutica Ag... (CE) is 4.03
      What is the reporting currency for Basilea Pharmaceutica Ag... (CE)?
      Basilea Pharmaceutica Ag... (CE) reports financial results in CHF
      What is the latest annual turnover for Basilea Pharmaceutica Ag... (CE)?
      The latest annual turnover of Basilea Pharmaceutica Ag... (CE) is CHF 150.28M
      What is the latest annual profit for Basilea Pharmaceutica Ag... (CE)?
      The latest annual profit of Basilea Pharmaceutica Ag... (CE) is CHF 10.45M
      What is the registered address of Basilea Pharmaceutica Ag... (CE)?
      The registered address for Basilea Pharmaceutica Ag... (CE) is GRENZACHERSTRASSE 487, BASEL, 4058
      What is the Basilea Pharmaceutica Ag... (CE) website address?
      The website address for Basilea Pharmaceutica Ag... (CE) is www.basilea.com
      Which industry sector does Basilea Pharmaceutica Ag... (CE) operate in?
      Basilea Pharmaceutica Ag... (CE) operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CRGPCalissio Resources Group Inc (CE)
      $ 0.0004
      (39,900.00%)
      		20k
      SMMESmartMetric Inc (PK)
      $ 0.0001
      (9,900.00%)
      		1.25M
      NEOMNeoMedia Technologies Inc (CE)
      $ 0.0001
      (9,900.00%)
      		534.97k
      RRGIReality Racing Inc (CE)
      $ 0.0001
      (9,900.00%)
      		209k
      ELIQQElectriq Power Holdings Inc (CE)
      $ 0.0001
      (9,900.00%)
      		290
      IBKKFImining Technologies Inc (CE)
      $ 0.000001
      (-100.00%)
      		100
      EGIOQEdgio Inc (CE)
      $ 0.000001
      (-99.99%)
      		905
      CYBFCyberfort Software Inc (CE)
      $ 0.000001
      (-99.88%)
      		20k
      CHMJDWaverunner Capital Inc
       0.0045
      (-99.40%)
      		106
      CCTLCoin Citadel (PK)
      $ 0.000001
      (-99.00%)
      		108k
      HMBLHUMBL Inc (PK)
      $ 0.0009
      (0.00%)
      		359.72M
      GRLFGreen Leaf Innovations Inc (PK)
      $ 0.00015
      (50.00%)
      		194.9M
      AITXArtificial Intelligence Technology Solutions Inc (PK)
      $ 0.00375
      (-1.32%)
      		188.36M
      TSOITherapeutic Solutions International Inc (PK)
      $ 0.0002
      (-33.33%)
      		168.26M
      PHILPHI Group Inc (PK)
      $ 0.00025
      (-16.67%)
      		129.87M

      Discussion

      View Full Feed
      Hi_Lo Hi_Lo 5 minutes ago
      Lol!! I want profits!! What you want helps me in no way!!
      Exactly. Because the truth with documentation that BCAP is a scam and Jake P. Noch is a serial scammer prevents pumping liars like you from making profits. And that's part of my goal - and to help people know the facts about this scam
      BCAP
      DiamondHealer95 DiamondHealer95 8 minutes ago
      What do you expect and how can you back your thoughts? Thanks
      KBLB
      DiamondHealer95 DiamondHealer95 14 minutes ago
      I mean Kim said once they hit 1.5 metric tons they're open for business and they're about halfway there so..... You're a genius! Congrats on the business. I also run one with 100% positive feedback over 22 years so I get the perspective🤪

      Also, in my Arby's voice "I have the
      KBLB
      DiamondHealer95 DiamondHealer95 18 minutes ago
      We've invested similarly
      KBLB
      sunspotter sunspotter 29 minutes ago
      Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
      VPLM
      Flobewan Flobewan 40 minutes ago
      Marc loved your ides
      tinojax tinojax 41 minutes ago
      I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
      PLUG
      mrfence mrfence 43 minutes ago
      Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
      [yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
      FMCC FNMA
      IVRT IVRT 59 minutes ago
      In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
      BMXI
      DewDiligence DewDiligence 59 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      ENTA
      DewDiligence DewDiligence 1 hour ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      Guido2 Guido2 1 hour ago
      This is DUE DILIGENCE! Thank you Free Fannie.

      https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
      FNMA
      StockItOut StockItOut 1 hour ago
      That Xeriant PR excellently written with bullshit:

      ""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

      "the Company used the data to make several key
      XERI
      gitreal gitreal 1 hour ago
      You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
      BMXI
      RichieBoy RichieBoy 1 hour ago
      Jim wrote a blurb about seeking more US business.

      Help you out any? 🤨
      AFFU
      DesktopDR DesktopDR 1 hour ago
      Any news or updates?
      VPLM
      Tahoe2468 Tahoe2468 1 hour ago
      .0915 by Thursday....... 
      KRTL
      skitahoe skitahoe 1 hour ago
      Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

      According to Google, GBM ha
      NWBO
      fuagf fuagf 1 hour ago
      You are right about the crafty, evil, smart. Authoritarian methods have been in full view
      in capturing America. While we work to do the right things they plot to capture the lot.
      facts_matter14 facts_matter14 1 hour ago
      If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






      .
      SRMX
      StockItOut StockItOut 2 hours ago
      Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
      XERI
      fuagf fuagf 2 hours ago
      He would smother any question with words.

      Your Recent History

      USOTC
      BPMUF
      Basilea Pharmaceutica Ag... (CE)
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads